Lipid management in Qatar in High CV-risk Patients: Why do we need novel therapeutics?
Lecture - Dec. 17, 2016 - Qatar - Dr. Hani Sabbour, Abu Dhabi, UAE - Master Class - PCSK9 Inhibiion in Clinical Lipid ManagementEducational information
This session is recorded at Master Class - PCSK9 Inhibition in Clinical Lipid Management
Disclosures
Dr Hani Sabbour is Consultant Cardiologist and Electrophysiologist -Clinical Professor of Cardiology, Cardiology Department Sheikh Khalifa Medical Center, Abu Dhabi , UAE
Funding
The meeting was sponsored by Sanofi Gulf